Sarepta CEO To Jump Ship After ‘Tumultuous’ Year

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) shares are down during Thursday’s premarket session as the company reported its fourth-quarter and full-year 2025 financial results. Over the last year, the company’s stock has plunged from $106.86 to $18.96, due to patient...